Microbiology
-
SARS-CoV-2 Omicron-B.1.1.529 Variant leads to less severe disease than Pango B and Delta variants strains in a mouse model of severe COVID-19
This article has 15 authors:Reviewed by ScreenIT
-
Intranasal inhibitor broadly blocks SARS-CoV-2 including recent highly immunoevasive Omicron subvariants
This article has 23 authors:Reviewed by ScreenIT
-
Effect of nebulised BromAc ® on rheology of artificial sputum: relevance to muco-obstructive respiratory diseases including COVID-19
This article has 5 authors:Reviewed by ScreenIT
-
SARS-CoV-2 BA.1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies
This article has 30 authors:Reviewed by ScreenIT
-
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
This article has 10 authors:Reviewed by ScreenIT
-
Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529
This article has 9 authors:Reviewed by ScreenIT
-
mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2
This article has 17 authors:Reviewed by ScreenIT
-
Expanded ACE2 dependencies of diverse SARS-like coronavirus receptor binding domains
This article has 5 authors:Reviewed by ScreenIT
-
Super-immunity by broadly protective nanobodies to sarbecoviruses
This article has 12 authors:Reviewed by ScreenIT
-
Improved binding affinity of the Omicron’s spike protein with hACE2 receptor is the key factor behind its increased virulence
This article has 3 authors:Reviewed by ScreenIT